Erratum: Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? (Strahlentherapie und Onkologie (189) (193-196) DOI: 10.1007/s00066-012-0300-3);Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy?: Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO)

Strahlentherapie und Onkologie

Volumn 189, Issue 3, 2013, Pages 193-196

  Sedlmayer, F ^a   Sautter Bihl, M L ^b   Budach, W ^c   Dunst, J ^d   Feyer, P ^e   Fietkau, R ^f   Haase, W ^g   Harms, W ^h   Rodel C ⁱ   Souchon, R ^j   Wenz, F ^k   Sauer, R ^f  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g formerly St Vincentius Kliniken   (Germany)

^h St Claraspital AG   (Switzerland)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^j UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^k UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; EDITORIAL; RADIOLOGICAL PROCEDURES; SIMULTANEOUSLY INTEGRATED BOOST TECHNIQUE; ADJUVANT THERAPY; AUSTRIA; BREAST TUMOR; CANCER STAGING; FEMALE; GERMANY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL SOCIETY; METHODOLOGY; MICROMETASTASIS; MINIMAL RESIDUAL DISEASE; ONCOLOGY; PATHOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEGMENTAL MASTECTOMY; TREATMENT OUTCOME;

AUSTRIA; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; GERMANY; HUMANS; LYMPHATIC IRRADIATION; MASTECTOMY, SEGMENTAL; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84876326097     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0349-7     Document Type: Erratum

References (24)

1. Bantema-Joppe EJ, Schilstra C, deBock GH et al (2012) Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up. Int J Radiat Oncol Biol Phys 83:e471-477
2. Bantema-Joppe EJ, van der Laan HP, de Bock GH et al (2011) Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival. Radiother Oncol 100:215-220
3. Bentzen SM, Yarnold JR (2010) Reports of unexpected late side effects of accelerated partial breast irradiation - radiobiological considerations. Int J Radiat Oncol Biol Phys 77:969-973
4. Baack T, Wenz F (2012) Secondary cancers after radiotherapy may appear early and atypical. Strahlenther Onkol 188:91-92; author reply 92-93
5. Chadha M, Vongtama D, Friedmann P et al (2012) Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer 12:57-62
6. Coles C, Yarnold J (2006) IMPORT Trials Management Group. The IMPORT trials are launched. Clin Oncol (R Coll Radiol) 18:587-590
7. Collette S, Collette L, Budiharto T et al (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882"boost versus no boost". Eur J Cancer 44:2587-2599
8. Donovan EM, James H, Bonora M et al. (2012) Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. Med Phys 39:5814-5824
9. Fowler JF (1992) Brief summary of radiobiological principles in fractionated radiotherapy. Sem Radiat Oncol 2:16-21
10. Freedman GM, Anderson PR, Bleicher RJ et al (2012) Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer. Int J Radiat Oncol Biol Phys 84:888-893
11. Freedman GM, Anderson PR, Goldstein LJ, et al (2007) Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 68:347-353
12. Goldsmith C, Haviland J, Tsang Y et al (2011) Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? Radiother Oncol 100:236-240
13. Hurkmans CW, Dijckmans I, Reijnen M et al (2012) Adaptive radiation therapy for breast IMRT-simultaneously integrated boost: three-year clinical experience. Radiother Oncol 103:183-187
14. Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C et al (2006) High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys 66:923-930
15. Jagsi R, Ben-David MA, Moran JM et al. (2010) Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76:71-78
16. Moody AM, Mayles WP, Bliss JM et al (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106-112
17. Mukesh M, Harris E, Jena R et al (2012) Relationship between irradiated breast volume and late normal tissue complications: a systematic review. Radiother Oncol 104:1-10
18. Nestle-Krämling C, Bölke E, Budach W et al (2011) [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review]. Strahlenther Onkol 187:656-664
19. Sautter-Bihl ML, Budach W, Dunst J et al (2007) DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I. Breast-Conserving Therapy. Strahlenther Onkol 183:661-666
20. Van Parijs H, Miedema G, Vinh-Hung V et al (2012) Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiation Oncology 7:80
21. Vrieling C, Collette L, Fourquet A et al (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC"boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55:219-232
22. Whelan T, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy of breast cancer. NEJM 362:513-520
23. Yang Z, Chen J, Xie J, et al.(2012) Simultaneous Integrated Boost in Breast Conserving Radiotherapy: Is Replanning Necessary Following Tumor Bed Change? Technol Cancer Res Treat Oct 19 (Epub ahead of print)
24. Yarnold J, Ashton A, Bliss J et al (2005) Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long - term results of a randomised trial. Radiother Oncol 75:9-17